University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Location status: Recruiting
Location contact
Adrian Smith, BS
CONTACT
Hon Yuen, PhD
CONTACT
Hon Yuen, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07655531
The goal of the study is to understand how well yogic breathing exercise and meditation improves breathing, fatigue, emotional well-being and quality of life in people with spinal cord disorders.
Aim 1. Evaluate the efficacy of an 8-week, virtual, coach-guided yogic breathing and meditation (YBM) program on QoL and mental health in people with spinal cord disorders.
This study will include completing several questionnaires 3 times, 8 weeks of participating in 2 sessions per week of yogic breathing exercise and meditation via Zoom and being interviewed once at the completion of the 8-week program.
Interested in participating?
Request Info18 year–89 year
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35294, United States
Location status: Recruiting
Adrian Smith, BS
CONTACT
Hon Yuen, PhD
CONTACT
Hon Yuen, PhD
PRINCIPAL_INVESTIGATOR
General Information You are being asked to take part in a research study. This research study is voluntary, meaning you do not have to take part in it. The procedures, risks, and benefits are fully described further in the consent form.
Purpose The purpose of the study is to understand how well yogic breathing exercise and meditation improves breathing, fatigue, and emotional well-being in people with spinal cord injury (SCI).
Duration & Visits You will complete several questionnaires (3 different times) that will take 30 minutes to complete each time, participate in 12-30-minute yogic breathing exercise and meditation sessions (over 8 weeks), complete a 25-minute interview and that you will be in the study for 2 months.
Overview of Procedures This study will include completing several questionnaires multiple times, 8 weeks of participating in 2 sessions per week of yogic breathing exercise and meditation via Zoom and being interviewed once.
Risks The most common risks include some tiredness and frustration while learning the yogic breathing exercise and meditation techniques. Loss of confidentiality is also a risk.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
yogic breathing exercise and meditation exercise
Time frame: change from baseline in depressive symptoms at 8 and 16 weeks
The Patient Health Questionnaire-9 (PHQ-9) consists of nine questions inquiring about symptoms experienced over the past two weeks, ranging from low energy and sleep issues to feelings of hopelessness and self-harm. Each question is scored from 0 to 3, with a maximum total score of 27. Higher scores indicate more severe depressive symptomology.
Time frame: baseline, post-program (8th week), and 16th week
The Patient Health Questionnaire-9 (PHQ-9) consists of nine questions inquiring about symptoms experienced over the past two weeks, ranging from low energy and sleep issues to feelings of hopelessness and self-harm. Each question is scored from 0 to 3, with a maximum total score of 27. Higher scores indicate more severe depressive symptomology.
Contact information is provided by the study sponsor or research team.
Adrian Smith, BS
CONTACT
Hon Yuen, PhD
CONTACT
University of Alabama at Birmingham
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07660250
Central Nervous System Diseases, Degenerative Cervical Myelopathy
St Louis, Missouri, United States
View Trial DetailsNCT07401186
Able Bodied, Brain Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05023772
Agnosia, Central Nervous System Diseases
Detroit, Michigan, United States
View Trial DetailsNCT05305430
Central Nervous System Diseases, Cervical Disc Degeneration
Windsor, Victoria, Australia
View Trial Details